| __timestamp | Ionis Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 16606000 |
| Thursday, January 1, 2015 | 322292000 | 21497000 |
| Friday, January 1, 2016 | 344320000 | 25462000 |
| Sunday, January 1, 2017 | 374644000 | 28195000 |
| Monday, January 1, 2018 | 1820000 | 33078000 |
| Tuesday, January 1, 2019 | 4000000 | 36523000 |
| Wednesday, January 1, 2020 | 12000000 | 41455000 |
| Friday, January 1, 2021 | 11000000 | 74400000 |
| Saturday, January 1, 2022 | 14000000 | 101582000 |
| Sunday, January 1, 2023 | 9133000 | 112903000 |
| Monday, January 1, 2024 | 11215000 |
Cracking the code
In the competitive world of biotechnology, cost efficiency can be a decisive factor for success. Ionis Pharmaceuticals, Inc. and Veracyte, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. Ionis Pharmaceuticals started with a high cost of revenue, peaking in 2017, but managed to reduce it by over 97% by 2023. This significant reduction reflects a strategic shift towards more efficient operations. In contrast, Veracyte, Inc. has seen a steady increase in its cost of revenue, rising by approximately 580% over the same period. This growth may indicate an expansion phase, potentially investing in new technologies or markets. Understanding these trends provides valuable insights into each company's operational strategies and market positioning.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Johnson & Johnson and Ionis Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Merck & Co., Inc. vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Trends: Gilead Sciences, Inc. vs Veracyte, Inc.
Cost of Revenue: Key Insights for Biogen Inc. and Veracyte, Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Catalent, Inc. and Veracyte, Inc.
Cost of Revenue Trends: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Pharming Group N.V. vs Veracyte, Inc.
Cost of Revenue Trends: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs MorphoSys AG: Efficiency in Cost of Revenue Explored
Alkermes plc vs Veracyte, Inc.: Efficiency in Cost of Revenue Explored